tradmap

BRTX BioRestorative Therapies, Inc.

$1.50 +6.38%

Data as of close

Healthcare · Services-Misc Health & Allied Services, Nec

BioRestorative Therapies, Inc. (BRTX) is a healthcare company in the Services-Misc Health & Allied Services, Nec industry, with a market capitalization of $2 million. Shares last traded at $1.50, 95.2% below their 52-week high. Over the past year the stock is down 95.3%. Revenue declined 10.3% year over year.

Market Cap
$2M
Shares Out
1.3M
EPS (TTM)
-$21.20
P/E (TTM)*
—
P/S Ratio
5.34
P/B Ratio
0.63
Dividend / Share
—
Dividend Yield
—
52-Week High
$31.40
52-Week Low
$1.38
Volume (venue)
321
Avg Vol (3m, venue)
543.641

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+0.00%
1M
-31.51%
3M
-65.28%
6M
-69.75%
YTD
-93.59%
1Y
-95.27%

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. BRTX split history →

Technicals

RSI (14)
35.65
SMA (50)
$2.46
SMA (200)
$6.25
Price vs SMA50
-38.91%
Price vs SMA200
-76.00%
ATR (14)
$0.14

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$357870
Net Income
-$11M
Gross Margin
92.1%
Operating Margin
—
Net Margin
—
Return on Equity
-365.4%
Return on Assets
-238.3%
Current Ratio
2.35
Debt / Equity
0.08
Revenue Growth (YoY)
-10.3%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-03-31. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 -$2.40 2026-05-14
Q4 2025 (derived) -$6.20 2026-03-26
FY 2025 -$31.60 2026-03-26
Q3 2025 -$6.60 2025-11-12
Q2 2025 -$6.00 2025-08-12
Q1 2025 -$12.80 2025-05-14

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Services-Misc Health & Allied Services, Nec peers

BRTX vs 11 industry peers (Services-Misc Health & Allied Services, Nec), by market cap. Data as of close

P/S vs peers
5.34 / 1.55 med
+244% premium
1–11 of 11
DVADaVita$11.7B12.700.826.5%-1.02%
SHCSotera Health Co$5.1B30.934.1613.4%-2.26%
PGNYProgyny, Inc.$2.3B28.711.726.0%+0.72%
AGLAgilon Health, Inc.$1.5B—0.25-3.9%+2.46%
VMDVIEMED HEALTHCARE, INC.$360M24.801.194.8%-2.48%
PARKPark Dental Partners, Inc.$100M———-0.54%
CCELCRYO CELL INTERNATIONAL INC$43M—1.39-6.2%+3.38%
MGRXMANGOCEUTICALS, INC.$5M—15.66—-2.51%
BRTXBioRestorative Therapies, Inc.$2M—5.34—+6.38%
NIVFNewGenIvf Group Ltd————-7.75%
FMSFresenius Medical Care Ag————+0.67%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.